The localization of high-value interventional consumables will benefit patients, and medical robots will “help” doctors to perform operations… These “black technologies” used in cutting-edge medical fields are expected to be realized in Shuangliu. Today (17th) afternoon, a reporter from Red Star News learned from a big health expert exchange meeting held by the Big Health Industry Office of Shuangliu District, Chengdu that Shuangliu will build a Tianfu Medical Center covering an area of about 292 acres within the Chengdu Tianfu International Biological City. Mechanical Valley. The entire project will be constructed in two phases, with an estimated investment of 3.2 billion yuan, targeting three sub-sectors of in vitro diagnosis, high-value consumables, and intelligent diagnosis and treatment equipment.
Rendering of Tianfu Medical Equipment Valley
At the meeting, expert representatives focused on the transformation of scientific and technological achievements and industrial construction of the big health industry in Shuangliu District. The circle strong chain work gave a special speech. Representatives of enterprises made speeches on Shuangliu health industry project construction, project recruitment, talent training, etc., raised demands and ideas, and asked experts for technology and guidance. At the event, various experts and business representatives communicated with the industry authorities, discussed the opportunities and challenges of the development of the big health industry, and worked together to draw a new blueprint for “healthy dual streams”.
Red Star News reporter learned from the meeting that relying on the advantages of Shuangliu District’s portal hub, innovative resources, platform policies, and industrial diversity, the Shuangliu health industry will focus on three major areas in the future. Among them, medical equipment is particularly noteworthy. The Shuangliu District Health Industry Office is taking the lead in building the Tianfu Medical Equipment Valley Industrial Project. The industrial development direction is mainly based on in vitro diagnosis, implantable biomedical materials and portable intelligent medical equipment. It will rely on the foundation of the core valley integrated circuit industry, focus on the development of “portable and intelligent” medical equipment, explore the development of medical imaging equipment, Intelligent medical equipment such as medical robots and wearable devices.
According to the relevant person in charge of the Shuangliu District Health Industry Office, Tianfu Medical Equipment Valley is a new industrial community with reasonable functional divisions, open park space, improved park facilities, and shared central greening. The net land area is about 292 mu, the planned total construction area is about 580,000 square meters, and the planned total investment is about 3.2 billion yuan. According to the “overall planning and phased construction”, the construction will be carried out in two phases according to the land supply. After the project is completed, it will become a favorable support point for the local health industry to become better and stronger, and further enhance the industrial ecological agglomeration, the construction of the industrial chain, and the operation of high-end elements.
“We will actively explore new models of industrial carriers, apply the new concept of ‘industrial upstairs’ to the Tianfu Medical Equipment Valley project, achieve a plot ratio of 3.0, greatly improve land use efficiency, and provide There is enough development space reserved for future industrial development.” said the relevant person in charge of the Shuangliu District Health Industry Office.
It is also understood that in addition to medical devices, the Shuangliu health industry will also focus on the development of pharmaceutical R&D and manufacturing, and pharmaceutical supply chain industries. In terms of pharmaceutical R&D and manufacturing, Shuangliu will focus on isotopes and drugs, introduce projects such as antibody drugs, cell therapy and gene therapy drugs, and focus on developing innovative drugs and new drug preparations. Guide existing enterprises in the jurisdiction to transform and upgrade, enrich product lines, and extend production outsourcing services with surplus production capacity.
In terms of pharmaceutical supply chain, it will rely on Shuangliu International Airport and Airport Bonded Logistics Center to build a comprehensive public service platform, integrate customs, drug supervision and other resources, develop biomedical customs declaration, import and export agency, etc. Serve. Upgrade and transform traditional logistics and warehousing, develop biomedical bonded warehousing and cross-border medical e-commerce, and form a pharmaceutical cold chain logistics hub covering the southwest.
In the future, Shuangliu will continue to deepen the implementation of building a circle and a strong chain, scientifically plan the industrial chain map, deepen research around the leading industry segment, compile the industry map, and sort out and identify the “chain master” enterprises in the leading industry segment. , and give full play to the integration power of the “chain master” enterprise on the industrial chain, the control power of the supply chain and the spillover power of the innovation chain.
Tang Jing, Wu Haoyan, Red Star News reporter Lei Haoran, according to Shuangliu District
Editor Chen Yixi
(Download Red Star News, there will be prizes for reporting materials!)
